REQUEST A DEMO
Total
USD $0.00
Search more companies

Generi Biotech S.R.O. (Czech Republic)

Main Activities: Research and Development in Nanotechnology | Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Pharmaceutical Preparation Manufacturing | Surgical and Medical Instrument Manufacturing | Custom Computer Programming Services | All Other Schools and Instruction
Full name: Generi Biotech S.R.O. Profile Updated: January 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Generi Biotech S.R.O. is based in Czech Republic. The head office is in Hradec Kralove. The company operates in the Research and Development in Nanotechnology sector. Generi Biotech S.R.O. was incorporated on June 08, 1995. It currently has a total number of 50 - 99 (2024) employees. There was a net sales revenue increase of 25.25% reported in Generi Biotech S.R.O.’s latest financial highlights for 2024. Its’ total assets recorded a growth of 3.93%.

Headquarters
U Fotochemy 1763
Hradec Kralove; Kralovehradecky; Postal Code: 50002

Contact Details: Purchase the Generi Biotech S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Generi Biotech S.R.O. report to view the information.
Registered Capital:
Purchase the Generi Biotech S.R.O. report to view the information.
Financial Auditors:
Purchase the Generi Biotech S.R.O. report to view the information.
Incorporation Date:
June 08, 1995
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Generi Biotech S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
25.25%
Total operating revenue
30.92%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total Assets
3.93%
Total Equity
7.37%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
4.31%
Cash Ratio
2.5%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?